Suppr超能文献

转谷氨酰胺酶 2 抑制剂 LDN 27219 随年龄依赖性降低血压并改善阻力动脉内皮依赖性血管舒张。

Transglutaminase 2 Inhibitor LDN 27219 Age-Dependently Lowers Blood Pressure and Improves Endothelium-Dependent Vasodilation in Resistance Arteries.

机构信息

From the Department of Biomedicine, Pulmonary and Cardiovascular Pharmacology, Aarhus University, Denmark (E.P., S.C.-S., J.P.-D., V.M., N.H.B., U.S.).

Departament of Physiology, Faculty of Pharmacy, Complutense University of Madrid, Spain (E.P., L.R.).

出版信息

Hypertension. 2021 Jan;77(1):216-227. doi: 10.1161/HYPERTENSIONAHA.120.15352. Epub 2020 Nov 30.

Abstract

Transglutaminase 2 (TG2) is an enzyme which in the open conformation exerts transamidase activity, leading to protein cross-linking and fibrosis. In the closed conformation, TG2 participates in transmembrane signaling as a G protein. The unspecific transglutaminase inhibitor cystamine causes vasorelaxation in rat resistance arteries. However, the role of TG2 conformation in vascular function is unknown. We investigated the vascular effects of selective TG2 inhibitors by myography in isolated rat mesenteric and human subcutaneous resistance arteries, patch-clamp studies on vascular smooth muscle cells, and blood pressure measurements in rats and mice. LDN 27219 promoted the closed TG2 conformation and inhibited transamidase activity in mesenteric arteries. In contrast to TG2 inhibitors promoting the open conformation (Z-DON, VA5), LDN 27219 concentration-dependently relaxed rat and resistance human arteries by a mechanism dependent on nitric oxide, large-conductance calcium-activated and voltage-gated potassium channels 7, lowering blood pressure. LDN 27219 also potentiated acetylcholine-induced relaxation by opening potassium channels in the smooth muscle; these effects were abolished by membrane-permeable TG2 inhibitors promoting the open conformation. In isolated arteries from 35- to 40-week-old rats, transamidase activity was increased, and LDN 27219 improved acetylcholine-induced relaxation more than in younger rats. Infusion of LDN 27219 decreased blood pressure more effectively in 35- to 40-week than 12- to 14-week-old anesthetized rats. In summary, pharmacological modulation of TG2 to the closed conformation age-dependently lowers blood pressure and, by opening potassium channels, potentiates endothelium-dependent vasorelaxation. Our findings suggest that promoting the closed conformation of TG2 is a potential strategy to treat age-related vascular dysfunction and lowers blood pressure.

摘要

转谷氨酰胺酶 2(TG2)是一种酶,在开放构象中具有转酰胺酶活性,导致蛋白质交联和纤维化。在封闭构象中,TG2 作为 G 蛋白参与跨膜信号转导。非特异性转谷氨酰胺酶抑制剂半胱胺可引起大鼠阻力血管舒张。然而,TG2 构象在血管功能中的作用尚不清楚。我们通过大鼠肠系膜和人皮肤阻力动脉的离体血管描记术、血管平滑肌细胞的膜片钳研究以及大鼠和小鼠的血压测量来研究选择性 TG2 抑制剂的血管作用。LDN 27219 促进了肠系膜动脉中 TG2 的封闭构象并抑制了转酰胺酶活性。与促进开放构象的 TG2 抑制剂(Z-DON、VA5)相反,LDN 27219 浓度依赖性地舒张大鼠和阻力性人血管,其机制依赖于一氧化氮、大电导钙激活和电压门控钾通道 7,降低血压。LDN 27219 还通过打开平滑肌中的钾通道增强乙酰胆碱诱导的舒张;这些作用被促进开放构象的膜透性 TG2 抑制剂所消除。在 35 至 40 周龄大鼠的分离动脉中,转酰胺酶活性增加,LDN 27219 改善乙酰胆碱诱导的舒张作用大于年轻大鼠。在麻醉大鼠中,LDN 27219 输注更有效地降低 35 至 40 周龄大鼠的血压,而不是 12 至 14 周龄大鼠。总之,TG2 向封闭构象的药理学调节随年龄降低血压,并通过打开钾通道增强内皮依赖性血管舒张。我们的发现表明,促进 TG2 的封闭构象是治疗与年龄相关的血管功能障碍和降低血压的潜在策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验